Caseware UK (AP4) 2024.0.164 2024.0.164 2025-04-302025-04-30false22024-05-01falseNo description of principal activity2truefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 07603582 c:Item1 d:UnitedKingdom 2024-05-01 2025-04-30 07603582 c:Item1 d:UnitedKingdom 2023-05-01 2024-04-30 07603582 c:CostSales 2024-05-01 2025-04-30 07603582 c:CostSales 2023-05-01 2024-04-30 07603582 c:CostSales c:Item1 2024-05-01 2025-04-30 07603582 c:CostSales c:Item1 2023-05-01 2024-04-30 07603582 c:AdministrativeExpenses 2024-05-01 2025-04-30 07603582 c:AdministrativeExpenses 2023-05-01 2024-04-30 07603582 c:AdministrativeExpenses c:Item1 2024-05-01 2025-04-30 07603582 c:AdministrativeExpenses c:Item1 2023-05-01 2024-04-30 07603582 c:AdministrativeExpenses c:Item2 2024-05-01 2025-04-30 07603582 c:AdministrativeExpenses c:Item2 2023-05-01 2024-04-30 07603582 c:Item1 2024-05-01 2025-04-30 07603582 c:Item1 2023-05-01 2024-04-30 07603582 c:Item2 2024-05-01 2025-04-30 07603582 c:Item2 2023-05-01 2024-04-30 07603582 2024-05-01 2025-04-30 07603582 2023-05-01 2024-04-30 07603582 2025-04-30 07603582 2024-04-30 07603582 e:Director1 2024-05-01 2025-04-30 07603582 e:Director2 2024-05-01 2025-04-30 07603582 e:RegisteredOffice 2024-05-01 2025-04-30 07603582 f:OfficeEquipment 2024-05-01 2025-04-30 07603582 f:OfficeEquipment 2025-04-30 07603582 f:OfficeEquipment 2024-04-30 07603582 f:OfficeEquipment f:OwnedOrFreeholdAssets 2024-05-01 2025-04-30 07603582 f:PatentsTrademarksLicencesConcessionsSimilar 2025-04-30 07603582 f:PatentsTrademarksLicencesConcessionsSimilar 2024-04-30 07603582 f:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-04-30 07603582 f:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-30 07603582 f:CurrentFinancialInstruments 2025-04-30 07603582 f:CurrentFinancialInstruments 2024-04-30 07603582 f:Non-currentFinancialInstruments 2025-04-30 07603582 f:Non-currentFinancialInstruments 2024-04-30 07603582 f:CurrentFinancialInstruments f:WithinOneYear 2025-04-30 07603582 f:CurrentFinancialInstruments f:WithinOneYear 2024-04-30 07603582 f:Non-currentFinancialInstruments f:AfterOneYear 2025-04-30 07603582 f:Non-currentFinancialInstruments f:AfterOneYear 2024-04-30 07603582 f:Non-currentFinancialInstruments f:BetweenOneTwoYears 2025-04-30 07603582 f:Non-currentFinancialInstruments f:BetweenOneTwoYears 2024-04-30 07603582 f:ShareCapital 2025-04-30 07603582 f:ShareCapital 2024-04-30 07603582 f:RetainedEarningsAccumulatedLosses 2025-04-30 07603582 f:RetainedEarningsAccumulatedLosses 2024-04-30 07603582 e:OrdinaryShareClass1 2024-05-01 2025-04-30 07603582 e:OrdinaryShareClass1 2025-04-30 07603582 e:OrdinaryShareClass1 2024-04-30 07603582 e:FRS102 2024-05-01 2025-04-30 07603582 e:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 07603582 e:FullAccounts 2024-05-01 2025-04-30 07603582 e:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 07603582 f:AcceleratedTaxDepreciationDeferredTax 2025-04-30 07603582 f:AcceleratedTaxDepreciationDeferredTax 2024-04-30 07603582 f:PatentsTrademarksLicencesConcessionsSimilar f:ExternallyAcquiredIntangibleAssets 2024-05-01 2025-04-30 07603582 f:DevelopmentCostsCapitalisedDevelopmentExpenditure f:ExternallyAcquiredIntangibleAssets 2024-05-01 2025-04-30 07603582 2 2024-05-01 2025-04-30 07603582 f:ExternallyAcquiredIntangibleAssets 2024-05-01 2025-04-30 07603582 f:PatentsTrademarksLicencesConcessionsSimilar f:OwnedIntangibleAssets 2024-05-01 2025-04-30 07603582 f:DevelopmentCostsCapitalisedDevelopmentExpenditure f:OwnedIntangibleAssets 2024-05-01 2025-04-30 07603582 g:PoundSterling 2024-05-01 2025-04-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 07603582









OSTEON LIMITED







UNAUDITED

DIRECTORS' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

 
OSTEON LIMITED
 
 
COMPANY INFORMATION


Directors
Giles Gyer 
Demetri Michael 




Registered number
07603582



Registered office
Grove House
2 Woodberry Grove

London

N12 0DR




Accountants
Gilchrists AB LLP
Chartered Certified Accountant

Grove House

2 Woodberry Grove

London

N12 0DR





 
OSTEON LIMITED
 

CONTENTS



Page
Directors' report
1
Accountants' report
2
Profit and loss account
3
Balance sheet
4 - 5
Notes to the financial statements
6 - 12
The following pages do not form part of the statutory financial statements:

Detailed profit and loss account and summaries
13 - 15


 
OSTEON LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 30 APRIL 2025

The directors present their report and the financial statements for the year ended 30 April 2025.

Directors

The directors who served during the year were:

Giles Gyer 
Demetri Michael 

Small companies note

In preparing this report, the directors have taken advantage of the small companies exemptions provided by section 415A of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 





Giles Gyer
Director

Date: 4 September 2025

Page 1

 
OSTEON LIMITED
 
 
  
REPORT TO THE DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF OSTEON LIMITED
FOR THE YEAR ENDED 30 APRIL 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Osteon Limited for the year ended 30 April 2025 which comprise the Profit and loss account, the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountantswe are subject to its ethical and other professional requirements which are detailed at https://www.accaglobal.com/en/uk/about-us/regulation/ethics/acca-rulebook.html.

This report is made solely to the Board of directors of Osteon Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Osteon Limited and state those matters that we have agreed to state to them in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/content/dam/ACCA_Global/Technical/fact/technical-factsheet-163.pdf. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Osteon Limited and its Board of directors, as a body, for our work or for this report. 

It is your duty to ensure that Osteon Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Osteon Limited. You consider that Osteon Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Osteon Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Gilchrists AB LLP
Chartered Certified Accountant
Grove House
2 Woodberry Grove
London
N12 0DR
4 September 2025
Page 2

 
OSTEON LIMITED
 
 
PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 30 APRIL 2025

2025
2024
Note
£
£

  

Turnover
  
428,894
403,481

Cost of sales
  
(131,501)
(113,925)

Gross profit
  
297,393
289,556

Administrative expenses
  
(102,004)
(129,350)

Operating profit
  
195,389
160,206

Interest receivable and similar income
  
12,301
-

Interest payable and similar expenses
  
(780)
(1,029)

Profit before tax
  
206,910
159,177

Tax on profit
  
(51,309)
(41,297)

Profit for the financial year
  
155,601
117,880

The notes on pages 6 to 12 form part of these financial statements.

Page 3

 
OSTEON LIMITED
REGISTERED NUMBER: 07603582

BALANCE SHEET
AS AT 30 APRIL 2025

2025
2024
Note
£
£

Fixed assets
  

Intangible assets
 4 
7,213
7,252

Tangible assets
 5 
9,395
10,440

  
16,608
17,692

Current assets
  

Debtors: amounts falling due within one year
 6 
4,391
10,294

Cash at bank and in hand
 7 
690,079
577,724

  
694,470
588,018

Creditors: amounts falling due within one year
 8 
(75,347)
(52,263)

Net current assets
  
 
 
619,123
 
 
535,755

Total assets less current liabilities
  
635,731
553,447

Creditors: amounts falling due after more than one year
 9 
(21,905)
(27,460)

Provisions for liabilities
  

Deferred tax
  
(2,349)
(2,610)

  
 
 
(2,349)
 
 
(2,610)

Net assets
  
611,477
523,377


Capital and reserves
  

Called up share capital 
 12 
100
100

Profit and loss account
 13 
611,377
523,277

  
611,477
523,377


Page 4

 
OSTEON LIMITED
REGISTERED NUMBER: 07603582
    
BALANCE SHEET (CONTINUED)
AS AT 30 APRIL 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




Demetri Michael
Director

Date: 4 September 2025

The notes on pages 6 to 12 form part of these financial statements.

Page 5

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

1.


General information

The company is a private company limited by shares, registered in England.The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.

If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.4

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Page 6

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

2.Accounting policies (continued)

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 7

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Practice equipment
-
10% Reducing Balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.11

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.12

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.13

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.

Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 8

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2024 - 2).


4.


Intangible assets




Osteon Website
Trade Mark
Total

£
£
£



Cost


At 1 May 2024
6,448
1,610
8,058


Additions
-
761
761



At 30 April 2025

6,448
2,371
8,819



Amortisation


At 1 May 2024
645
161
806


Charge for the year on owned assets
580
221
801



At 30 April 2025

1,225
382
1,607



Net book value



At 30 April 2025
5,223
1,989
7,212



At 30 April 2024
5,803
1,449
7,252



Page 9

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

5.


Tangible fixed assets





Practice equipment

£



Cost or valuation


At 1 May 2024
25,677



At 30 April 2025

25,677



Depreciation


At 1 May 2024
15,238


Charge for the year on owned assets
1,044



At 30 April 2025

16,282



Net book value



At 30 April 2025
9,395



At 30 April 2024
10,439


6.


Debtors

2025
2024
£
£


Trade debtors
4,128
8,224

Director loan account
-
1,854

PAYE/NI recoverable
263
216

4,391
10,294



7.


Cash and cash equivalents

2025
2024
£
£

Cash at bank
690,079
577,724

690,079
577,724


Page 10

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

8.


Creditors: Amounts falling due within one year

2025
2024
£
£

Bank loans
6,335
6,335

Trade creditors
10,580
581

Corporation tax
51,512
38,687

Director loan account
260
-

Accruals
6,660
6,660

75,347
52,263



9.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Bank loans
21,905
27,460

21,905
27,460



10.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Amounts falling due within one year

Bank loans
6,335
6,335


6,335
6,335

Amounts falling due more than 1 year

Bank loans
21,905
27,460


21,905
27,460



28,240
33,795


Page 11

 
OSTEON LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2025

11.


Deferred taxation




2025


£






At beginning of year
(2,610)


Charged to profit or loss
261



At end of year
(2,349)

The provision for deferred taxation is made up as follows:

2025
2024
£
£


Deferred tax
2,349
2,610

2,349
2,610


12.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) 100Ordinary Shares shares of £1.00 each
100
100



13.


Reserves

2025
2024
£
£



Profit and loss account - b/fwd
523,276
474,097

Profit for the year
155,601
117,880

Dividends
(67,500)
(68,700)

611,377
523,277


14.


Related party transactions

Included within direct expenses are management  services fees of £10,580 (2024 - £10,255) payable to G & M Properties (London) Limited, a company where Demetri Michael and Giles Gyer are directors and shareholders.

Page 12

 
OSTEON LIMITED
 
 
DETAILED PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 30 APRIL 2025

2025
2024
Note
£
£

Turnover
  
428,894
403,481

Cost Of Sales
  
(131,500)
(113,925)

Gross profit
  
297,394
289,556

Gross profit %
69.3%
71.8%

Less: overheads
  

Administration expenses
  
(102,005)
(129,350)

Operating profit
  
195,389
160,206

Interest receivable
  
12,301
-

Interest payable
  
(780)
(1,029)

Deferred tax - current year
  
261
(2,610)

Tax on profit on ordinary activities
  
(51,570)
(38,687)

Profit for the year
  
155,601
117,880

 Page 13

 
OSTEON LIMITED
 
 
 
SCHEDULE TO THE DETAILED ACCOUNTS
FOR THE YEAR ENDED 30 APRIL 2025


2025
2024
£
£

Turnover

Turnover
428,894
403,481

428,894
403,481


2025
2024
£
£

Cost of sales

Medical supplies, consumables, direct expenses, travel & location cost
52,413
61,775

Teaching staff,advertisement,teaching room hire and professional medical cover
79,087
52,150

131,500
113,925


2025
2024
£
£

Administration expenses

Directors salaries
24,000
24,000

Workplace pension 
346
346

Directors pension
52,000
80,000

Printing and stationery
2,575
1,865

Technology cost
9,429
9,340

Charity donations
-
100

Payroll,annual return and register office
1,599
1,738

Accountancy fees
6,660
6,840

Bank charges
846
703

Office cost & service
311
358

Insurances
2,394
2,094

Depreciation - tangible assets
1,044
1,160

Amortisation - intangible fixed assets
801
806

102,005
129,350


2025
2024
£
£

Interest receivable

Bank interest receivable
12,301
-

12,301
-


 Page 14

 
OSTEON LIMITED
 
 
 
SCHEDULE TO THE DETAILED ACCOUNTS
FOR THE YEAR ENDED 30 APRIL 2025


2025
2024
£
£

Interest payable

Bank loan interest payable
780
923

Other interest - on overdue tax
-
106

780
1,029


 Page 15